|Bid||14.65 x 1100|
|Ask||16.70 x 3200|
|Day's Range||14.57 - 15.07|
|52 Week Range||5.11 - 17.77|
|Beta (5Y Monthly)||1.75|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||16.00|
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to participate in three upcoming virtual investor conferences.
The big shareholder groups in Pulse Biosciences, Inc. (NASDAQ:PLSE) have power over the company. Generally speaking...
With that, I would now like to turn the call over to President and Chief Executive Officer, Darrin Uecker. Throughout these difficult times, our team has shown unwavering dedication in their efforts to bring our technology to the market.